Related Experiment Videos
Modifications of antitumor defenses by tumor derived factors and by superantigens
1Department of Microbiology and Immunology, University of Miami School of Medicine, FL 33101.
Abstract:
There is ample evidence that tumor development can be affected by the interactions between the growing neoplasms and the immune system. The balance of these interactions is tilted in favor of tumor growth in many cases due to the production of cytokines and other factors by the tumor cells. These factors can modulate the immune system either by direct interactions with immune cells or by indirect means, which include downregulation of the synthesis of other cytokines or products necessary for the activity of a given effector cell. In addition, endogenous retroviral superantigens, with their capacity of eliminating part of the T cell repertoire and possibly by other effects on cells of the T and B cell lineages, may provide the tumor cells an escape from the otherwise efficient antitumor host defenses.
Insights
Tumor cells can evade immune defenses by producing factors that suppress immune cell activity. Endogenous retroviral superantigens may also help tumors escape the immune system, aiding tumor growth.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Tumor development is influenced by complex interactions between neoplasms and the host immune system.
- In many cancers, this balance favors tumor progression due to tumor-derived factors.
- These factors can suppress anti-tumor immune responses through direct or indirect mechanisms.
Purpose of the Study:
- To elucidate the mechanisms by which tumor cells modulate the immune system to promote their own growth.
- To investigate the role of tumor-produced cytokines and other factors in immune evasion.
- To explore the potential contribution of endogenous retroviral superantigens to tumor escape from host defenses.
Main Methods:
- Analysis of cytokine production by tumor cells.
- Investigation of the effects of tumor-derived factors on immune cell function.
- Assessment of the impact of endogenous retroviral superantigens on T and B cell repertoires.
Main Results:
- Tumor cells secrete cytokines and other factors that inhibit immune cell activity.
- These factors can downregulate essential immune components, impairing anti-tumor responses.
- Endogenous retroviral superantigens may eliminate T cells and affect B cells, facilitating tumor escape.
Conclusions:
- Tumor cells actively subvert immune surveillance through molecular and cellular mechanisms.
- Cytokine production and retroviral superantigens represent key strategies for tumor immune evasion.
- Understanding these interactions is crucial for developing effective cancer immunotherapies.